These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9179231)
1. In vivo study of a technetium labelled anti-EGFr MoAB. Scopinaro F; De Vincentis G; Banci M; Schillaci O; Di Loreto M; Danieli R; Ierardi M; De Paola AM; Gianni W; Massa R Anticancer Res; 1997; 17(3B):1761-5. PubMed ID: 9179231 [TBL] [Abstract][Full Text] [Related]
2. Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma. Sogawa C; Tsuji AB; Yoshida C; Inubushi M; Furukawa T; Koizumi M; Akahori Y; Ukai Y; Kurosawa G; Kurosawa Y; Saga T Nucl Med Commun; 2012 Jul; 33(7):719-25. PubMed ID: 22453549 [TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor. Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer. Teramoto T; Onda M; Tokunaga A; Asano G Cancer; 1996 Apr; 77(8 Suppl):1639-45. PubMed ID: 8608556 [TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979 [TBL] [Abstract][Full Text] [Related]
7. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer. de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data. Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain. Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator. Andersson KG; Oroujeni M; Garousi J; Mitran B; Ståhl S; Orlova A; Löfblom J; Tolmachev V Int J Oncol; 2016 Dec; 49(6):2285-2293. PubMed ID: 27748899 [TBL] [Abstract][Full Text] [Related]
11. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts. Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037 [TBL] [Abstract][Full Text] [Related]
12. Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody. Foulon CF; Reist CJ; Bigner DD; Zalutsky MR Cancer Res; 2000 Aug; 60(16):4453-60. PubMed ID: 10969792 [TBL] [Abstract][Full Text] [Related]
13. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule. Ceriani RL; Blank EW Cancer Res; 1988 Aug; 48(16):4664-72. PubMed ID: 3396015 [TBL] [Abstract][Full Text] [Related]
14. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Fan Z; Masui H; Altas I; Mendelsohn J Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927 [TBL] [Abstract][Full Text] [Related]
15. Scintigraphic detection of xenografted renal tumor by anti-renal cancer monoclonal antibody radiolabeled with technetium-99m. Mitsui K; Taki T; Miyagawa Y; Yamada Y; Honda N; Fukatsu H; Yoshikawa K; Segawa A Hinyokika Kiyo; 1995 Aug; 41(8):593-601. PubMed ID: 7572438 [TBL] [Abstract][Full Text] [Related]
16. Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor. Crombet T; Torres O; Neninger E; Catalá M; Rodríguez N; Ramos M; Fernández E; Iznaga N; Pérez R; Lage A Cancer Biother Radiopharm; 2001 Feb; 16(1):93-102. PubMed ID: 11279803 [TBL] [Abstract][Full Text] [Related]
17. Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats. Capala J; Barth RF; Bailey MQ; Fenstermaker RA; Marek MJ; Rhodes BA Bioconjug Chem; 1997; 8(3):289-95. PubMed ID: 9177833 [TBL] [Abstract][Full Text] [Related]
18. [The study of radioimmunoimaging on the nude mice bearing human ovarian carcinoma by labelling monoclonal antibody with 99mTc]. Lin W; Qian H; Feng J Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):308-10. PubMed ID: 9206189 [TBL] [Abstract][Full Text] [Related]
19. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284 [TBL] [Abstract][Full Text] [Related]
20. Effects of monoclonal antibody anti-EGF receptor on human nasopharyngeal carcinoma cell and other tumor cells. Guan EN; Zhou TC; Wang JH; Chen Y; Sun YX; Huang PG; Tang WP; Zhao ML Sci China B; 1990 Nov; 33(11):1334-40. PubMed ID: 2095159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]